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Alexander Salava* and Antti LauermaAbstract
Atopic dermatitis (AD) is a common inflammatory skin disorder and characterized by abnormalities in both skin barrier
structures and alternations of the immune response. Molecular genetics have dramatically changed our vision of the
micro-organisms colonizing the human skin and recently well-documented changes in the skin microbiome in atopic
dermatitis have become evident. The microbiome shifts have been primarily documented during disease flares and
localized to sites of disease predilection, e.g. folds or facial area. In contrast, active treatment has been associated
with a recolonisation and higher cutaneous microbial diversity. Additionally to the known dysfunctions in barrier
function of the skin (e.g. filaggrin mutations) and immunologic disturbances (e.g. Th2-shift), evidence is rising that
atopic dermatitis is also connected to a dysbiosis of the microbial community without an invading pathogen. In the
future the investigation of the patient’s skin microbiome may have a foothold in the clinician’s diagnostic repertoire
and treatment of atopic dermatitis.
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The skin microbiome
Human skin can be considered as a complex ecosystem.
An area of approximately 2.0 square meters can accom-
modate a great variety of habitats ranging from wet
skin in the axillary folds to drier areas of the shins. As
primarily an interface between the outside environment
the skin is inhabited by a number of micro-organisms
such as bacteria, fungi, mites and viruses [1]. The
current understanding is that the majority of these
micro-organisms is harmless and can even provide pro-
tection against harmful effects. The interaction be-
tween the host and the skin microbiome can be viewed
as a symbiosis. For the protection from pathogenic or-
ganisms the commensal microbial flora receives as a
compensation an area of skin to colonize and ecological
niche in the host [2]. Additionally skin microbes have
been found to play an important role in the modulation
of the host’s cutaneous native and adaptive immune
system. Communication with apathogenic commensal
microbes is likely partly training cutaneous T-cells to
recognize correct antigens and develop an adequate im-
mune response [3].* Correspondence: alexander.salava@hus.fi
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article, unless otherwise stated.Understanding the skin as an ecosystem
From a simplified perspective, it is primarily the physical
and chemical characteristics of a particular skin area
that determine the microbial flora. In particular skin
thickness, number of skin folds as well as the amount of
cutaneous appendages, i.e. sweat and sebaceous glands,
hair follicles and their activity have a substantial effect
on the skin microbiome. On the other hand, host char-
acteristics like age, gender and moreover immunological
factors have an influence on the composition of the mi-
crobial flora, so that the normal resident commensal
flora has been shown to vary significantly at different
body sites [4].
Some differences have been in part explained by the
physiological and anatomical differences between men
and women's skin, such as sweat and sebum quantity, as
well as differences in sex hormone production. Further-
more occupation, environmental factors, such as clothing
and the use of topical or systemic antibiotics, cosmetics,
soaps, personal care products and moisturizers are also
possible factors that affect the skin micro-organisms.
Studies of habitat and the influence of cultural aspects of
society have shown that high-temperature and moisture
(e.g. seen in areas of warm humid climate) is associated
with increased amount and a broader spectrum of bac-
teria on the skin [5]. Interestingly, on dry skin a domin-
ance of gram negative bacteria has been observed [2].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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number of bacterial species and colonization of micro-
organisms takes place immediately after birth [6]. A
very interesting area for future research will be the de-
velopment and eventual establishment of the cutane-
ous microbial diversity during the first years of life
and possible connections to skin diseases like atopic
dermatitis [7].
Interaction of microbiome and host-immune system
The immunological barrier of the skin
It has become apparent that the skin represents not only
a physical barrier but also as an immunological one and
that the composition of the microbiome is influenced by
the host’s native and adaptive immune system. A critical
function of the epithelium is the cutaneous innate im-
mune system, which orchestrates when and how the
immune system should respond to commensal or patho-
genic microbes. The epidermis directly borders with the
environment and expresses e.g. many pattern recogni-
tion receptors (PRRs) that make it a key player in cuta-
neous innate immune responses to skin infections and
injury. Thus, the cutaneous innate immune system can
be viewed as a key determinant of the immunologic barrier
functions of the epidermis. Malfunctions in this system can
lead to an inadequate host response to a pathogen or a per-
sistent inflammatory state [8].
Secondly, the immune cells of the adaptive immune
system, especially intraepithelial lymphocytes, have showed
to be involved in maintaining the integrity of the epithelial
surfaces. They seem to contribute towards the tolerance to
commensal apathogenic micro-organisms and to adequate
immune responses against harmful organisms and their
products. Complex and prolonged interactions between
the skin microbiome and host immune system of skin
and mucous membranes have been described. Recent
publications have gained further insight to the role of
the cutaneous adaptive immune system by examining the
microbiome of patients with rare primary immunodefi-
ciencies, e.g. Hyper-IgE-syndrome or Wiskott-Aldrich-
syndrome [9]. Interestingly, while there is a great difference
in the specific immunologic defect, a shared hallmark is a
clinical picture imitating atopic dermatitis.
Effect of the microbiome on the host’s immune system
Interactions with skin commensals are now understood
as a key in developing cutaneous immunity. In atopic
dermatitis some data exist that the cutaneous microbes
can vice versa, have an impact on the hosts immune
system. One possibility is that the skin microbes may
alter the activation of cutaneous immunity. The elevated
serum IgE-levels in these patients may be related to al-
lergy or atopy and may also reflect an aberrant response
to a colonizing microbe [3].New molecular approaches to examine cutaneous
microbial flora
New innovations in sequencing technology and molecular
diagnostic methods, Next Generation Technologies, have
revolutionized our understanding of the skin microbiome
in recent years and have enabled explorations of the com-
plexity of the immense human-associated microbiota in
recent years. They have also emphasized the balanced
interaction between the microbes and the host [10].
As a result of genomic studies based on 16S ribosomal
RNA metagenomic sequencing it has become evident
that the skin colonization of microorganisms has a
greater diversity and variability than previously assumed
[11,12]. Based on 16 S ribosomal RNA polymorphisms
the skin bacteria can be divided into four phyla: Actino-
bacteria, Firmicutes, Proteobacteria and Bacteroidetes.
These seem to prevail also on the adjacent mucous
membranes. There have also been reports of detection
of 16S ribosomal RNA in deep skin layers, indicating
that the microbiome could extend to subepidermal com-
partments of normal skin [13]. The proportions of these
different bacterial phyla seem to vary greatly in different
areas of the skin. Current knowledge indicates that the
proportions and the established microbiome, however,
remain surprisingly stable during the life span and in an
individual [14].
However, the used methods of molecular genetics have
some disadvantages. For example they are not able to
distinguish between bacterial 16 S rRNA genes, which
are derived from living or dead organisms. In conclusion
they represent in vitro tests. As the skin is exposed to
a multitude of environmental influences and micro-
organisms, it is impossible to determine which of the
identified species represent transient and permanent
colonization. Additionally it is not possible to acquire in-
formation about sensitivity to antibiotics sensitivity, e.g. to
separate methicillin-sensitive and methicillin-resistant
Staphylococcus aureus (MRSA) species [15].
The microbiome in atopic dermatitis
The complex pathogenesis of atopic dermatitis
Atopic dermatitis is the most common inflammatory
skin disorder and characterized by abnormalities in both
skin barrier structures (e.g. filaggrin gene loss-of func-
tion mutations), a robust Th2-response to environmental
antigens, possible deficiencies in innate immunity and a
well-documented alternation of the skin microbiome
[16]. Many of these abnormalities may occur as the con-
sequence of epidermal dysfunction (Figure 1).
Changes in the skin microbiome
The disease development is believed to be strongly influ-
enced by the host’s immune response. Immunological
factors (e.g. Th2-shift) are thus understood to play major
Figure 1 Typical lichenified atopic dermatitis in the kneefolds.
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balance of the microbiome and the host’s cutaneous
immune response have been shown to aggravate atopic
dermatitis and lead to secondary skin infections [17]
(Figure 2). During flares, patients with atopic dermatitisFigure 2 Secondarly infected atopic dermatitis on the face of an adolshow an altered skin microbiome. After adequate ther-
apy the skin microbiome has been shown to regenerate.
In atopic dermatitis the effect of narrowband UV-therapy
has been documented quite well and shows an increase
in microbial diversity [18,19]. It has been postulated thatescent.
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endogenous (e.g. genetic polymorphisms in antimicrobial
peptides of the native immune system) or exogenous
(e.g. excessive hand washing and irritation) factors [20].
However it remains largely unclear whether the changes
seen in the skin microbiome of are due shifts in the bal-
ance of the immune response or occur secondarily be-
cause of permeability barrier changes [21]. The role of the
intestinal microbiota in the pathogenesis of atopic derma-
titis has been investigated recently, but the establishment
of the intestinal microbiome and its role for atopic derma-
titis in early childhood remain uncertain [22].
Decrease in the cutaneous microbial diversity
A hallmark of AD is the chronic, recurrent flaring of in-
tensely itchy skin. In recent studies there has been a
strong association between worsening disease severity
and lower skin bacterial diversity in the absence of re-
cent treatment. The microbiome shifts have been pri-
marily localized to sites of disease predilection, e.g. folds
or facial area. In contrast, intermittent or active treat-
ment is associated with higher bacterial diversity.
In one study intermittent-treatment flare patients who
used sporadic treatments in the week preceding flare
sampling, there was an early shift toward a diverse
microbiome in the presence of active clinical disease
suggesting that known effective treatments in atopic
dermatitis (topical corticosteroids, topical calcineurin in-
hibitors and basic emollients) diversify the skin bacterial
community [15] (Figures 3 and 4). It was shown how-
ever, that in the presence of active clinical disease during
intermittent-treatment flares lesional skin requires con-
tinued intensive treatment to sufficiently reduce the in-
flammatory response. Increases in microbial diversity
associated with treatments may be based on therapies that
preferentially kill Staphylococcus aureus and consequentlyFigure 3 Decreased cutaneous microbial diversity, colors indicate diffpermitting the relative expansion of apathogenic bacteria.
A possible other explanation is the promotion of microbes
that control S. aureus predominance or a general reduction
of skin microbes, which is followed by a prompt recolon-
isation with a community of broader diversity [21].
Many dermatologic disorders present with a typical
clinical distribution and atopic dermatitis can be con-
sidered as a prime example. Correspondingly the site-
specificity of skin bacterial communities proposes that
not only do particular ecological niches of the skin favor
the growth of certain bacteria, but that the local skin
microbiome is important in the initiation and continu-
ance of the disease.
Role of Staphylococcus aureus
In recent years particular attention has been paid to the
role of the Gram positive bacterium Staphylococcus aureus
in atopic dermatitis [23]. There has been some evidence
that during flares of atopic dermatitis the skin microbiome
changes to more susceptible towards Staphylococcus aureus
colonization [24]. In flares an increase of otherwise
commensal Staphylococcus epidermidis colonisation
and an appearance of Staphylococcus aureus colonization
has been observed frequently [18]. It has been shown, that
variations in the skin microbiome can modulate the inter-
action of genes and environment on the surface of the skin
and thus have a proven impact on the skin's immune
defense [25]. Recently, an example has been described
how the host and cutaneous microbial flora join forces
against pathogenic microbes. The usually apathogenic
Staphylococcus epidermidis has been shown to inhibit
pathogenic Staphylococcus aureus colonization and
biofilm formation on the skin [26].
Current studies have shown that atopic dermatitis
might at least partly have an underlying microbial etiology
and clinical improvement was seen with antimicrobialerent bacterial phyla.
Figure 4 Normal broad cutaneous microbial diversity.
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organisms have a secondary role, but only little is under-
stood about their contribution and the pathogenesis.
Many important questions are rising about the host-
microorganism relationship and its relevance. Atopic
dermatitis often occurs in characteristic areas of the
skin such as the elbows and knee folds, which could be
partly explained by differences in the skin microbiome.
Whether these specificities are driven by the endogen-
ous microbial community structure or is only an epi-
phenomenon due to secondary changes, e.g. changes
in the skin barrier in atopic dermatitis (e.g. flaggrin
mutations) or immunologic factors (e.g. Th2-shift),
remains to be determined. However the characteristic
changes in microbial colonization have awoken an
interest in developing new diagnostic methods and
treatments [27].
Future perspectives
Microbes are traditionally considered as discrete causa-
tive agents, but this perspective is beginning to change.
On human skin they exist within a rich milieu of other
microbial species that can influence pathogenicity. Add-
itionally to the known dysfunctions in barrier function
of the skin and immunologic disturbances, evidence is
rising that atopic dermatitis is also connected to a dys-
biosis of the microbial community without an invading
pathogen dominating the community.
Until now, the reported changes of cutaneous microbial
diversity in atopic dermatitis have been quite characteris-
tic for a particular disease state (stable or exacerbated)
and possibly as a prognostic factor (disease development)
and therefore may compose a potential diagnostic tool inthe future. Novel molecular techniques to identify and
quantify microbial organisms have to date proved to be
sensitive and less-biased thus representing a possible sub-
sidiary to clinical and microscopic diagnostics. Together
with the clinical information these advances could point
toward bacteria as new diagnostic and therapeutic targets
in atopic dermatitis.
Molecular genetics have dramatically changed our vision
of the micro-organisms colonizing the human skin. Im-
portant new questions have arisen in atopic dermatitis: the
host micro-organisms interaction and its relationship to
the pathogenesis of the disease, the concept of a dysbiosis
and potential therapeutic strategies and the role of anti-
microbial treatments. While it is clear that many of the
dominant organisms (including Staphylococcus species)
form a large part of the skin microbiome, very little is still
understood of rare or transient organisms in atopic derma-
titis. And, it is still unclear what factors are driving the
changes in skin microbiome during flares of the disease
[28]. Novel fields in skin microbiome research include the
role of micro-organisms other than bacteria, e.g. fungi or
viruses, in atopic dermatitis. For example there have been
some reports of microbiome shifts in cutaneous com-
mensal fungi (Malassezia species, 18S ribosomal RNA
techniques) in atopic dermatitis [29].
However, there is emerging a new understanding of
the skin microbiome in atopic dermatitis, which has
proven to more complex and interesting than previously
assumed. Future molecular genetic studies may solve
several aspects of the pathogenesis of the disease. The
investigation of the patient’s skin microbiome may also
have a foothold in the clinician’s diagnostic repertoire
and treatment of atopic dermatitis.
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